Pacific Biosciences Of California PACB
NASDAQ PACB
$1.96 +0.12 (+6.52%)
At close: Oct 20, 2026 · 4:00 PM EDT

Pacific Biosciences Of California (PACB) Restructuring Costs (2021 - 2023)

Updated

Pacific Biosciences Of California (PACB) recorded Restructuring Costs of $63,000 in Q4 2023, down 99.3% from the prior quarter.

Analysis

Pacific Biosciences Of California (PACB) Restructuring Costs (2021 - 2023) Analysis & Trends

For FY2023, Pacific Biosciences Of California reported Restructuring Costs of $9.04 million.

  • Across earlier years, Restructuring Costs came in at $31.13 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 254.87 Bn 233.89 Bn 4.88 Bn
2 Abbott Laboratories 178.85 Bn 149.28 Bn 7.27 Bn
3 Danaher 158.49 Bn 142.30 Bn 3.61 Bn
4 Intuitive Surgical 154.99 Bn 134.41 Bn 1.96 Bn
5 Medtronic 121.02 Bn 86.28 Bn 6.34 Bn
6 Stryker 116.94 Bn 103.05 Bn 4.50 Bn
7 Boston Scientific 66.98 Bn 61.75 Bn 3.85 Bn
8 Becton Dickinson 53.23 Bn 50.38 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Pacific Biosciences Of California 613.54 Mn -477.45 Mn 12.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 63,000.00
Sep 30, 2023 8.98 Mn
Dec 31, 2021 403,000.00
Sep 30, 2021 30.73 Mn
API Access

Pacific Biosciences Of California Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=PACB&period=max&api_key=YOUR_API_KEY